BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34619680)

  • 1. The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer.
    Kono Y; Inoue R; Teratani T; Tojo M; Kumagai Y; Morishima S; Koinuma K; Lefor AK; Kitayama J; Sata N; Horie H
    Digestion; 2022; 103(2):141-149. PubMed ID: 34619680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
    Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
    Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
    Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
    Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Oral Microbiota May Have Influence on Oral Cancer.
    Zhang L; Liu Y; Zheng HJ; Zhang CP
    Front Cell Infect Microbiol; 2019; 9():476. PubMed ID: 32010645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
    Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
    Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon.
    Zorron Cheng Tao Pu L; Yamamoto K; Honda T; Nakamura M; Yamamura T; Hattori S; Burt AD; Singh R; Hirooka Y; Fujishiro M
    J Gastroenterol Hepatol; 2020 Mar; 35(3):433-437. PubMed ID: 31609493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections.
    Malik SA; Zhu C; Li J; LaComb JF; Denoya PI; Kravets I; Miller JD; Yang J; Kramer M; McCombie WR; Robertson CE; Frank DN; Li E
    World J Gastroenterol; 2021 Apr; 27(14):1465-1482. PubMed ID: 33911468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Mucosa-Associated Microbiota in Matched Cancer and Non-neoplastic Mucosa From Patients With Colorectal Cancer.
    Leung PHM; Subramanya R; Mou Q; Lee KT; Islam F; Gopalan V; Lu CT; Lam AK
    Front Microbiol; 2019; 10():1317. PubMed ID: 31244818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
    Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
    BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients.
    Li Y; Cao H; Fei B; Gao Q; Yi W; Han W; Bao C; Xu J; Zhao W; Zhang F
    Front Cell Dev Biol; 2022; 10():916961. PubMed ID: 35721506
    [No Abstract]   [Full Text] [Related]  

  • 19. Profiling Fusobacterium infection at high taxonomic resolution reveals lineage-specific correlations in colorectal cancer.
    Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Cai C; Wei Q; Qin H
    Nat Commun; 2022 Jun; 13(1):3336. PubMed ID: 35680952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.